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a  b  s  t  r  a  c  t
The  present  study  was  carried  out to  evaluate  the  role  of Nigella  sativa  Linn  (NsL)  oil  against
subacute  tramadol-induced  hepatotoxicity,  nephrotoxicity  as  well  as  oxidative  stress  in
adult  male  albino  rats.  Sixty  adult  male  albino  rats  were divided  into  four groups.  Group
I:  control  group;  30 rats  equally  subdivided  into:  Ia; −ve control  group,  Ib; +ve control
group  received  saline,  Ic;  +ve  control  group  received  corn  oil. Group  II: 10  rats  received
NsL  oil;  1 mg/kg  in 1 ml corn  oil/day,  group III: 10 rats  received  tramadol;  30 mg/kg/day,
group  IV: 10  rats  received  tramadol  +  NsL  oil in  the previous  doses.  Treatments  were  given
by gavage  for  30 days.  Then  rats  were  sacriﬁced  and  specimens  from  the livers  and  kid-
neys  were  taken  for biochemical  and  histopathological  study.  Biochemical  data  showed
elevated  liver  enzymes;  alanine  transaminase  (ALT),  aspartate  transaminase  (AST),  gamma
glutamyltransferase  (GGT),  bilirubin  as  well  as urea  and  creatinine  in tramadol  group.
A signiﬁcant  increase  in  hepatic  and renal  malondialdehyde  (MDA)  and  a decrease  in
glutathione  peroxidase  (GPx)  levels  were  also  noticed.  Histological  analysis  of  the  liver
showed  vacuolated  hepatocyte  cytoplasm  indicating  hydropic  degeneration  with  binucle-
ated cells,  apoptotic  nuclei,  congested  central  veins,  cellular  inﬁltration  and  hemorrhage.
Kidney  sections  revealed  atrophied  glomeruli  with  collapsed  tufts  and  wide  Bowman’s
space,  degenerated  tubules,  hemorrhage  and  mononuclear  cellular  inﬁltration.  There  was
also  an  increase  in area %  of  collagen  ﬁbers  in both  organs.  Concomitant  use  of NsL oil
with  tramadol  induced  partial improvement  in  the  hepato-  and  nephrotoxic  effects.  In
conclusion,  this  study  suggested  that  concomitant  use of NsL  oil  with  tramadol  proved  to
be capable  of  ameliorating  tramadol-induced  hepato-  and  nephrotoxicity  which  might  be
due to its antioxidant  potential.
©  2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
Y-NC-Nthe  CC  BAbbreviations: NsL, Nigella sativa Linn; ALT, alanine transaminase;
AST, aspartate transaminase; GGT, gamma  glutamyltransferase; GPx,
glutathione peroxidase; MDA, malondialdehyde; ANOVA, analysis of vari-
ance.
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1. Introduction
Tramadol is a synthetic centrally acting analgesic with
effects similar to those of codeine and 10 times less than
morphine [1]. Tramadol has a wide range of applications
mostly in the treatment of moderate to severe, acute or
chronic pain [2]. Tramadol appears to be an ideal anal-
gesic during and after day case surgery and in patients with
acute ureteric spasm [3]. Studies have shown tramadol
to be effective in both acute myocardial infarction and
cess article under the CC BY-NC-ND license (http://creativecommons.org/
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nstable angina [4]. Tramadol has also been used in treat-
ent of cancer pain, moderate to severe musculoskeletal
ain, rheumatoid arthritis, restless legs syndrome, motor
euron disease, ﬁbromyalgia, diabetic neuropathy and
ost-herpetic neuralgia [5,6].
Tramadol is metabolized mainly in the liver by
ytochrome P450 (CYP2D6), cytochrome P4503A (CYP3A4)
nd cytochrome P450 isozyme (CYP2B6), being O-
nd N-demethylated to ﬁve different metabolites, fol-
owed by conjugation with glucuronic acid and sulphate
48].
Tramadol toxic effects should be kept in mind dur-
ng long-term therapy especially in large doses [7].
ide-spread use of tramadol makes associated hepato-
oxicity a clinically and economically important problem
8].
Tramadol and its metabolites are excreted via kidneys,
onsequently the kidney is considered to be the primary
arget organ for tramadol toxicity [8].
Turrens [9] stated that oxidative stress is an expres-
ion used to describe various deleterious processes
esulting from an imbalance between the excessive for-
ation of reactive oxygen species and limited antioxidant
efenses. The effects of reactive oxygen species are wide-
anging, but three reactions are particularly relevant
o cell injuries which are lipid peroxidation of mem-
ranes, oxidative modiﬁcation of proteins and lesions in
NA [10].
Nigella sativa Linn (NsL) oil is an annual herbaceous
lant belonging to the Ranunculaceae family growing in
ountries bordering the Mediterranean Sea, Pakistan, India
nd Iran [11]. NsL oil seed was found to contain more
han 30% ﬁxed oil, and 0.4–0.45% volatile oil. The ﬁxed
il is composed mainly of unsaturated fattyacids. Thy-
oquinone is the major active component of the volatile
il [12].
Many medicinal properties have been attributed to NsL
il seed extract and/or its oil, including antihistaminic, anti-
ypertensive, analgesic, anti-inﬂammatory, hypoglycemic,
ntibacterial, antifungal, antitumour as well as protec-
ive effects against hepatotoxicity and nephrotoxicity
11,13].
In addition, NsL oil has clear antioxidant properties and
an be used against oxidative stress by increasing antiox-
dant enzymes activities and decreasing oxidant enzymes
ctivities [14].
Therefore, the aim of this work was to evaluate the role
f NsL oil against subacute tramadol-induced hepatotoxic-
ty, nephrotoxicity as well as oxidative stress in adult male
lbino rats.
. Materials and methods
.1. Material
.1.1. Chemicals
Tramadol tablets, each contains 225 mg  tramadolydrochloride obtained from October Pharma Company
Giza, Egypt). Nigella sativa Linn oil (NsL oil) 2oz/60 ml  –
00% pure, undiluted – obtained from El-Captain Company
Cairo, Egypt). Saline (500 ml)  solution; 0.9% NaCl (solventports 2 (2015) 512–519 513
of tramadol) and corn oil (solvent of NsL oil) were also
obtained.
2.1.2. Kits
Kits of alanine transaminase (ALT), aspartate transam-
inase (AST), gamma  glutamyltransferase (GGT), serum
bilirubin, creatinine and urea, glutathione peroxidase
(GPX) and malondialdehyde (MDA) were purchased from
Biodiagnostic Co. (Giza, Egypt).
The study was  carried out on 60 adult male albino rats,
their weights ranging from 250 to 300 g for each. They
were obtained from the Animal House of the Faculty of Vet-
erinary Medicine, Zagazig University. The study had been
conducted in the Animal House of the Faculty of Medicine,
Zagazig University in accordance with the guidance of ethi-
cal committee for research on laboratory animals [15]. The
study protocol was approved by the Institutional Review
Board of the faculty of Medicine, Zagazig University, Egypt
(ZU-IRB-910).
Experimental design:  The rats were randomly divided
into four groups as follow:
Group I (control group): 30 rats, equally subdivided into
three subgroups:
Subgroup Ia (negative control group): Rats received only
regular diet and tap water for 30 days to measure the basic
parameters.
Subgroup Ib (positive control group) with saline: Each rat
received 1 ml  normal saline/day, orally for 30 days.
Subgroup Ic (positive control group) with corn oil: Each
rat received 1 ml  corn oil/day, orally for 30 days.
Group II (NsL oil group): 10 rats received NsL oil (1 ml/kg
in 1 ml  corn oil/day), orally for 30 days (each rat received
0.2 ml  (about 315 mg), each 1 ml  in 1 ml  corn oil [16].
Group III (tramadol-treated group): 10 rats treated with
tramadol (30 mg/kg/day), orally for 30 days. This dose is
1/10 of LD50. LD 50 is 286–300 mg/kg [17,18].
Group IV (tramadol + NsL oil-treated group): 10 rats
treated with tramadol along with NsL oil in the previous
doses.
At the time of sacriﬁce, rats were anaesthetized with
ether and then blood samples were collected from the
retro-orbital plexuses. The liver and kidneys of each rat
were dissected out carefully. Each specimen was divided
into two parts; one part was  wrapped with aluminum foil
and kept frozen at −80 ◦C till they were used for measure-
ment of MDA  content and GPx level and the other part was
preserved for histopathological examination.
3. Methods
3.1. Biochemical analysis
3.1.1. Assessment of liver and kidney function tests
The blood samples were used for estimation of serum
alanine transaminase (ALT) as described by Reitman
and Frankel [19], aspartate transaminase (AST) accord-
ing to Thomas [20], serum gamma  glutamyltransferase
(GGT) according to Gendler [49], total serum bilirubin
as described by Mallay and Evelyn [21] and urea and
ology Re514 A. Elkhateeb et al. / Toxic
creatinine according to Orsonneau et al. [22] and Fossati
et al. [23], consequently.
3.1.2. Preparation of liver and kidney homogenate
Liver and kidney tissues were homogenized with 10
times (w/v) ice-cold 0.1 M phosphate buffer pH (7.4).
Aliquots of homogenates were used to determine lipid per-
oxidation and glutathione peroxidase. GPx activity was
measured by the method of Paglia and Valentine [24].
Malondialdehyde (MDA) was assayed according to the
method proposed by Ohkawa et al. [25].
3.1.3. Histopathological examination
Liver and kidney specimens (1 cm thick) of different
groups were ﬁxed in 10% buffered formalin solution and
processed to obtain parafﬁn sections of 5 m thickness.
The sections were stained with hematoxylin and eosin and
Masson’s trichrome stains [26].
3.1.4. Quantitative morphometric analysis
The area percentage of collagen ﬁbers was measured in
Masson’s trichrome-stained sections. The measurements
were obtained using computer-based image analysis soft-
ware (Leica Qwin 500; Imaging Systems, Cambridge, UK) at
the image analyzing unit of the Pathology department, Fac-
ulty of Dentistry, Cairo University – Egypt. Measurements
were performed in 10 non-overlapping ﬁelds for each rat
of four randomly chosen rats of each group at 400×.
3.2. Statistical analysis
Data were represented as means ± SD. The differences
were compared for statistical signiﬁcance by ANOVA and
post hoc Tukey’s tests. Difference was considered signiﬁ-
cant at p < 0.05. The statistical analysis was performed using
a software (SPSS Inc., Chicago, IL, USA).
4. Results
4.1. Biochemical resultsStatistical comparison between negative and positive
control groups as regard liver and kidney function tests and
oxidative stress markers revealed no signiﬁcant difference
(p > 0.05) by ANOVA test (Table 1). So, the negative control
Table 1
Comparison among negative control, positive control (saline) and positive contr
(IU/L),  GGT (IU/L), total bilirubin (mg/dl), urea (mg/dl) and creatinine (mg/dl), usi
Parameters Groups 
Negative control
N  = 10
Positive control sali
N = 10
X ± SD
ALT (IU/L) 50.32 ± 3.78 48.46 ± 2.1 
AST (IU/L) 157.18 ± 3.17 157.53 ± 1.92 
GGT (IU/L) 48.52 ± 2.93 49.07 ± 2.43 
Total serum bilirubin (mg/dl) 0.36 ± 0.11 0.37 ± 0.08 
Urea (mg/dl) 42.86 ± 1.70 42.19 ± 1.19 
Creatinine (mg/dl) 0.89 ± 0.05 0.86 ± 0.04 
N: number of rats in each group.
# P > 0.05 (non-signiﬁcant).ports 2 (2015) 512–519
group was used for comparison with the other groups of the
study. No signiﬁcant differences in the mean values of the
liver and kidney function tests were noticed between NsL
oil group and negative control group. However, there was  a
highly signiﬁcant increase in the mean values of serum ALT,
AST, GGT, total bilirubin, urea and creatinine in tramadol-
treated group as compared to the negative control group
(p < 0.001). Although tramadol + NsL oil group revealed a
signiﬁcant decrease in the mean values of serum ALT, AST,
GGT, total bilirubin, urea and creatinine when compared
with tramadol-treated group (p < 0.001), the values of the
above mentioned parameters were still higher than those
of the negative control group (Table 2).
As regard the mean values of the oxidative stress
markers (MDA and GPx) in the liver and kidney tissues,
non-signiﬁcant differences were noticed between NsL oil
group and negative control group. On the other hand,
a signiﬁcant increase in the MDA  level was  observed in
tramadol-treated group when compared to the negative
control. NsL oil group showed a signiﬁcant decrease in the
MDA  level in comparison to the tramadol group. The results
of tramadol + NsL oil group revealed a signiﬁcant decrease
in the mean values of liver and kidney MDA  level when
compared with that of tramadol-treated group (p < 0.001),
but still non-signiﬁcantly higher than the negative con-
trol group. In addition, rats treated with tramadol showed
a highly signiﬁcant decrease in the GPx level when com-
pared to the negative control group (p < 0.001). In NsL oil
group, a signiﬁcant increase in GPx level was noticed in
comparison to the tramadol group (p < 0.001). As regarding
tramadol + NsL oil group, the results revealed a signiﬁ-
cant increase in the mean values of liver and kidney GPx
level when compared with that of tramadol-treated group
(p < 0.001), but still non signiﬁcantly lower than the nega-
tive control group (Table 3).
4.2. Histopathological results
4.2.1. The liver
Examination of liver specimens taken from the control
groups and NsL oil group showed normal liver archi-
tecture with trabeculae of normal hepatocytes running
radiantly from central veins, and separated by sinusoids.
Hepatocytes revealed acidophilic stippled cytoplasm and
vesicular nuclei. The portal areas contained branches of the
ol (corn oil) groups as regard the mean values of serum ALT (IU/L), AST
ng ANOVA test.
F P
ne (1 ml/kg) Positive control corn oil (1 ml/kg)
N = 10
49.26 ± 1.34 0.759 0.49#
158.42 ± 1.21 0.481 0.63#
49.63 ± 1.26 0.343 0.72#
0.35 ± 0.14 0.079 0.924#
41.57 ± 1.27 1.255 0.313#
0.85 ± 0.04 1.542 0.25#
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Table  2
Comparison of the mean values of liver function tests [serum ALT (IU/L), AST (IU/L) & GGT (IU/L), total bilirubin] and kidney function tests [serum urea
&creatinine] of negative control, NsL oil, tramadol, and tramadol + NsL oil groups using ANOVA test and post hoc Tukey’s test.
Parameters Groups
Negative control
N = 10
NsL oil group
N = 10
Tramadol group
N = 10
Tramadol + NsL oil group
N = 10
F P
X ± SD
ALT (IU/L) 50.32 ± 3.78 38.05 ± 16.72 145.01 ± 5.37a 94.64 ± 6.1a,b 157.068 0.001**
AST (IU/L) 157.18 ± 3.17 151.35 ± 1.47 194.03 ± 15.7a 167.77 ± 2.9b 32.058 0.001**
GGT (IU/L) 48.52 ± 2.93 41.72 ± 1.54 78.94 ± 5.22a 60.19 ± 5.49b 93.202 0.001**
Total Serum
Bilirubin (mg/dl)
0.36 ± 0.11 0.38 ± 0.19 0.66 ± 0.14a 0.41 ± 0.02b 14.17 0.001**
Urea (mg/dl) 42.86 ± 1.7 39.02 ± 0.96 74.56 ± 5.27a 52.41 ± 8.56b 58.097 0.001**
Creatinine(mg/dl) 0.89 ± 0.05 0.79 ± 0.02 1.81 ± 0.12a 1.51 ± 0.13a 165.648 0.001**
N: number of rats in each group.
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Na Signiﬁcant difference (p < 0.05) when compared with the negative con
b Signiﬁcant difference (p < 0.05) when compared with tramadol-treate
** Highly signiﬁcant (P < 0.001).
epatic artery and bile duct, embedded in connective tissue
Fig. 1a and b). Tramadol-treated group showed vacuolated
epatocytes’ cytoplasm indicating hydropic degeneration,
ith congested central veins. Some hepatocytes were bin-
cleated while others contained apoptotic nuclei. The
ortal tract revealed proliferated bile ducts, cellular inﬁl-
ration and ﬁbrosis of blood vessels. Hemorrhage was  also
bserved (Fig. 1c–e). Co-administration of NsL oil along
ith tramadol revealed improved liver architecture. How-
ver, there was congestion of central veins which indicate
artial improvement (Fig. 1f). Masson’s trichrome-stained
ections of the negative control group showed few col-
agen ﬁbers in the portal tract. The collagen ﬁbers were
ncreased in tramadol-treated group. Tramadol + NsL oil-
reated group showed decreased amount of collagen ﬁbers
n comparison to that of tramadol treated group (Fig. 2a
nd c).
.2.2. The kidney
Examination of H&E-stained sections of the kidney of
he control and NsL oil groups showed normal glomeruli,
ach contained a tuft of glomerular capillaries surrounded
y visceral and parietal layers of Bowman’s capsule which
re separated by narrow Bowman’s space. Sections of
he proximal and distal convoluted tubules were seen
ined with cuboidal epithelium with strongly eosinophilic
able 3
omparison of the mean values of oxidative stress markers: MDA (nmol/mg prote
nd  tramadol + NsL oil groups using ANOVA test and post hoc Tukey’s test.
Parameters Groups 
Negative control
N = 10
NsL oil group
N = 10
MDA  (mmol/l)
Liver 90.86 ± 2.62 79.63 ± 3.63 
Kidney 89.36 ± 1.13 76.08 ± 3.73 
GPx (ng/ml)
Liver 19.59 ± 0.71 25.03 ± 2.66
Kidney 21.18 ± 1.55 26.05 ± 1.38 
: number of rats in each group.
a Signiﬁcant difference (p < 0.05) when compared with the negative control gro
b Signiﬁcant difference (p < 0.05) when compared with tramadol group.
** P < 0.001 highly signiﬁcant.up.
.
cytoplasm and vesicular central rounded nuclei (Fig. 3a).
Tramadol-treated group showed atrophied glomerulus
with collapsed tuft, wide Bowman’s space, degenerated
tubules, cellular inﬁltration and haemorrhage. Haemorr-
hage and mononuclear cellular inﬁltration were also seen
(Fig. 3b). Co-administration of NsL oil along with tramadol
revealed partial improvement with structure of the kid-
ney nearly similar to control group. However, there were
slightly wide Bowman’s space, some vacuolated tubular
cells and mild congestion of peritubular capillaries (Fig. 3c).
Using Masson’s trichrome stain, the negative con-
trol group showed few collagen ﬁbers in the glomerular
basement membrane, mesangium and Bowman’s cap-
sule (Fig. 4a). The collagen ﬁbers were increased in the
tramadol-treated group (Fig. 4b). Co-administration of tra-
madol and NsL oil showed decreased amount of collagen
ﬁbers in kidney sections of rats of this group when com-
pared with that of tramadol treated rats (Fig. 4c).
4.3. Morphometric results
Non-signiﬁcant difference in area % of collagen ﬁbers
was detected in sections of liver and kidney of NsL oil and
negative control groups. There was  a signiﬁcant increase
in area % of collagen ﬁbers in sections of liver and kid-
ney of tramadol-treated group when compared to the
in), SOD (U/ml) and CAT (U/ml) of the negative control, NsL oil, tramadol
P
Tramadol group
N = 10
Tramadol + NsL group
N  = 10
148.83 ± 3.97a 97.74 ± 1.13b 0.001**
136.27 ± 12.39a 94.55 ± 2.45b 0.001**
12.96 ± 1.01a 17.23 ± 0.98b 0.001**
13.67 ± 1.83a 17.85 ± 0.35b 0.001**
up.
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Fig. 1. A photomicrograph of sections in rat liver of all studied groups. (a and b) Negative control group showing in (a): sheets of normal hepatocytes
(arrow) with acidophilic stippled cytoplasm and vesicular nuclei radiating from central vein (v) and separated by sinusoids (s). (b) Portal area with hepatic
artery  (A) and bile duct (d), embedded in connective tissue (ct). (c–e) Tramadol-treated group showing in c): hepatocytes with vacuolated cytoplasm
(arrow), indicating hydropic degeneration, and congested central veins (v). (d) Some hepatocytes are binucleated (short arrow). The portal tract reveals
proliferated bile ducts (d), cellular inﬁltration (double arrow) and ﬁbrosis of blood vessels (f). (e) Many hepatocytes showing hydropic degeneration (long
arrow), apoptotic nuclei (green arrow head) others are binucleated (short arrow). Hemorrhage (hg) is also seen. (f) Tramadol + NsL oil-treated group showing
improved liver architecture, and hepatocytes showing eosinophilic cytoplasm however there is congested central veins (v) [H&E 400×].
Fig. 2. Sections in rat liver showing distribution of collagen ﬁbers (arrow) in all studied groups. (a) Negative control group showing few collagen ﬁbers in
the  portal tract. (b) Tramadol-treated group shows increased collagen ﬁbers in portal tract. (c) Tramadol + NsL oil-treated group shows decreased amount
of  collagen ﬁbers in the portal tract [Masson’s trichrome 400×].
Table 4
Comparison between the area percentages (area %) of collagen ﬁbers in the different studied groups.
Parameters Groups
Negative control NsL oil Group Tramadol group Tramadol + NsL oil group
Area %of collagen ﬁbers
Liver 0.35 ± 0.09 0.48 ± 0.11 3.93 ± 1.23a 0.58 ± 0.13b
Kidney 7.48 ± 1.6 8.45 ± 1.9 20.3 ± 3.52a 12.14 ± 2.33a,b
a Signiﬁcant difference (p < 0.05) when compared with the negative control group.
b Signiﬁcant difference (p < 0.05) when compared with tramadol group.
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Fig. 3. A photomicrograph of renal sections from all studied groups. (a) Negative control group: showing a glomerulus (G) composed of a tuft of glomerular
capillaries, surrounded by visceral and parietal layers of Bowman’s capsule, separated by narrow Bowman’s space. Proximal (p) and distal (d) convoluted
tubules are also seen. (b): Tramadol-treated group showing atrophied glomerulus with collapsed tuft (G), wide Bowman’s space (*) and degenerated tubules
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egative control. However, a signiﬁcant decrease in area %
f collagen ﬁbers was found in the liver and kidney of tra-
adol + NsL oil group in comparison to tramadol-treated
roup (Table 4).
. Discussion
Tramadol is available worldwide as a synthetic centrally
cting analgesic for treatment of moderate to severe, acute
r chronic pain [2]. The role of the liver and the kidneys in
ramadol metabolism and excretion predisposes them to
oxic injury [18].
In the present study, the liver functions were impaired
n tramadol-treated group as reﬂected by elevation of
erum ALT, AST, GGT and total bilirubin. Similar results
ere obtained by Wu et al. [27], Atici et al. [28] and Janssen-
rtho Inc. [8] who reported signiﬁcant increase in the levels
f serum ALT, AST and LDH (lactate dehydrogenase) in rats
fter long term usage of tramadol.
Serum ALT is relatively speciﬁc, affected early by hepa-
otoxicity and is considered an excellent marker of cellular
ecrosis, as it is a cytoplasmic enzyme [47]. On the other
and, AST is mainly a mitochondrial enzyme. Although its
levated level in the serum is not speciﬁc of the hepatic
isorder, AST is used mainly to diagnose and to verify per-
istent cellular injury with other enzymes like ALT [29].
The histopathological results of the current work sup-
orted the toxic effect of tramadol on the liver as
ramadol-treated rats showed hydropic degeneration of
ig. 4. (a) The negative control group showing few collagen ﬁbers in the glomerula
apsule (green arrow). (b) Tramadol-treated group showing increased collagen ﬁbe
arrow)  and Bowman’s space (green arrow). (c) Tramadol + NsL oil-treated group sh
ead),  and nearly normal collagen distribution in both mesangium (arrow) and Bamadol + NsL oil -treated group showing nearly normal structure of the
ow) and mild congestion of peritubular capillaries (c) are also seen [H&E
hepatocytes, apoptotic nuclei and occasional binucleation.
There were also congestion of central veins, proliferated
bile ducts, cellular inﬁltration, haemorrhage and ﬁbrosis of
blood vessels. These changes coincided with Loughrey et al.
[30] who reported that daily administration of tramadol at
a dose of (40 mg/kg body weight) to adult male rats for
one month was accompanied by hepatic congestion, hem-
orrhage and necrosis. Also, El-Wessemy [31] reported loss
of architecture, congested central veins, expanded portal
area with edema and inﬂammatory reaction in rats treated
with tramadol.
For explaining the previous ﬁndings, Muhtaseb et al.
[32] and Appiah et al. [33] stated that hepatotoxic chem-
icals cause liver damage through lipid peroxidation and
other oxidative damages. In agreement, Abdel-Zaher et al.
[34] found that repeated administration of tramadol for
several consecutive days to mice resulted in development
of oxidative stress in tissues.
Our biochemical results supported the previous theory
as assessment of oxidative stress markers revealed a sig-
niﬁcant increase in the MDA  level and a decrease in the
GPx level in tramadol-treated group when compared to
the control. It was reported that MDA  is widely accepted
as a sensitive biomarker of lipid peroxidation. It is consid-
ered a useful measure of oxidative stress status [35]. Also,
GPx enzymes were found to contain a transition metal as a
cofactor. The interaction of tramadol with metals of these
enzymes may  explain the observed inhibition in the activ-
ities of these enzymes [36].
r basement membrane (arrow head), mesangium (arrow) and Bowman’s
rs around the glomerular basement membrane (arrow head), mesangium
owing few collagen ﬁbers in the glomerular basement membrane (arrow
owman’s capsule (green arrow) [Masson’s trichrome 400]×.
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Nehru and Anand [37] postulated that elevation in
hepatic (ALT, AST, LDH) indices could be a secondary event
following tramadol-induced lipid peroxidation of hepa-
tocyte with the subsequent increase in the leakage of
these biomarkers from the liver. Lipid peroxidation of cell
membranes leads to loss of membrane ﬂuidity, changes in
membrane potential and an increase in membrane perme-
ability, all of which lead to leakage of the enzymes from the
liver cells.
In our study, impairment of the renal functions in
tramadol-treated rats was indicated by a signiﬁcant
increase in serum urea and creatinine, as compared to the
control group. Similar results were obtained by Atici et al.
[28] and El-Gaafarawi [38].
Noori and Mahboobe [39] suggested that renal insuf-
ﬁciency associated with tramadol may  be due to the
decreased glomerular ﬁltration rate or secondary to the
increase in reactive oxygen species. On the contrary,
Nagaoka et al. [40] reported that tramadol did not change
renal blood ﬂow (RBF) despite its increased serum nor-
epinephrine (NE) levels and subsequently increased mean
arterial blood pressure (MAP). This was attributed to
that the maximal serum NE concentration that tramadol
induced was 360 pg/mL, a concentration considered too
small to reduce RBF (although it did transiently increase
MAP).
Also, a histopathological evidence of renal damage was
observed after administration of tramadol 30 days in the
form of glomeruli with collapsed tufts and wide Bow-
man’s space, atrophic tubules, sloughing of tubular cells,
cellular inﬁltration, and hemorrhage. These results were in
agreement with Nehru and Anand [37] who reported that
reactive oxygen species generation and lipid peroxidation
are responsible for tramadol-induced nephrotoxicity. The
previous theory coincides with our results which revealed
an increase in MDA  level and a decrease GPx level in kid-
neys of rats receiving tramadol.
Abdel-Zaher et al. [34] reported that administration of
tramadol to normal mice resulted in depletion of GPx and
subsequent potentiation of lipid peroxidation in kidney
cortical slices resulting in inhibition of protein synthesis,
and mitochondrial damage.
Moreover, the results of the current work revealed
increased collagen ﬁbers in Masson’s trichrome-stained
sections of the liver and kidneys of tramadol-treated rats.
Surazynski et al. [41] stated that collagen is not only a struc-
tural component of extracellular matrix, but it has also been
recognized as a ligand for integrin receptors, which play
an important role in signaling that regulate ion transport,
lipid metabolism, kinase activation and gene expression.
Therefore, changes in the quantity, structure and distri-
bution of collagens in tissues may  affect cell signaling,
metabolism and function. Altindag et al. [42] suggested
that the increased collagen ﬁbers occur due to decreased
collagen metabolism that may  be related with oxidative
stress.
In the current study, concomitant use of NsL oil
along with tramadol produced partial improvement in the
hepato- and nephrotoxic effects together with the antiox-
idant effect evidenced by signiﬁcant reduction of MDA
content and elevation of GPx levels. According to Padhyeports 2 (2015) 512–519
et al. [13], NsL oil can protect against hepatotoxicity by reg-
ulating the actions of the ultrastructures of liver cells, and
normalizing the values of hepatic enzymes.
Also, the protective effect of NsL oil could be attributed
to the ability to antagonize the enhanced lipid peroxi-
dation, and in turn stabilize the integrity of the cellular
membranes leading to prevention or at least decreasing the
leakage of liver enzymes [43,44].
Saleem et al. [45] and Yaman and Balikci [46] reported
nephroprotective effect of NsL oil against gentamycin-
induced nephrotoxicity in rabbits where NsL oil lowered
the values of serum creatinine and blood urea nitrogen,
decreased the tubular necrosis score and prevented the
degenerative changes in kidney tissues.
In conclusion, our results indicated that the mixture of
corn oil and NsL oil alleviated the toxic effects of tramadol
on the liver and kidney including the histopathological and
biochemical changes as well as the oxidative damage. The
protective effect of NsL oil could be due to its antioxidant
potential by scavenging the free radicals. So, patients using
tramadol for long times should be checked regularly for
their liver and kidney functions. Our study revealed that
administration of NsL oil during tramadol treatment would
be beneﬁcial. Medicinal preparations that combine tra-
madol and NsL oil might decrease the toxic tramadol effects.
Other studies on dose-dependent effects of NSL oil are also
recommended.
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